Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
- Conditions
- Interventions
- First Posted Date
- 2009-04-23
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 305
- Registration Number
- NCT00887146
- Locations
- 🇺🇸
Mount Carmel Health Center West, Columbus, Ohio, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 756
- Registration Number
- NCT00881361
- Locations
- 🇺🇸
Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸Contra Costa Regional Medical Center, Martinez, California, United States
🇺🇸Mercy Medical Center, Baltimore, Maryland, United States
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 430
- Registration Number
- NCT00880191
- Locations
- 🇺🇸
Marshfield Clinic - Weston Center, Weston, Wisconsin, United States
🇺🇸Hope Cancer Care Center at Longmont United Hospital, Longmont, Colorado, United States
🇺🇸Illinois CancerCare - Eureka, Eureka, Illinois, United States
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Interventions
- First Posted Date
- 2009-03-26
- Last Posted Date
- 2020-02-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 217
- Registration Number
- NCT00869401
- Locations
- 🇺🇸
Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
🇺🇸Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark, Ohio, United States
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
- First Posted Date
- 2009-03-25
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 1822
- Registration Number
- NCT00869206
- Locations
- 🇺🇸
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
🇺🇸Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 24
- Registration Number
- NCT00867321
- Locations
- 🇺🇸
Illinois CancerCare - Community Cancer Center, Normal, Illinois, United States
🇺🇸Community Hospital of Ottawa, Ottawa, Illinois, United States
🇺🇸Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 34
- Registration Number
- NCT00863512
- Locations
- 🇺🇸
Good Samaritan Cancer Center, Puyallup, Washington, United States
🇺🇸Alvin and Lois Lapidus Cancer Institute at Sinai Hospital, Baltimore, Maryland, United States
🇺🇸Medical City Dallas Hospital, Dallas, Texas, United States
Acute Pain Caused by Paclitaxel in Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-03-11
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 306
- Registration Number
- NCT00860041
- Locations
- 🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸Michiana Hematology-Oncology, PC - Elkhart, Elkhart, Indiana, United States
🇺🇸Doctors Hospital at Ohio Health, Columbus, Ohio, United States
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2017-09-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 83
- Registration Number
- NCT00826540
- Locations
- 🇺🇸
Graham Hospital Association, Canton, Illinois, United States
🇺🇸Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸Siouxland Hematology Oncology Associates, Sioux City, Iowa, United States
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT00820872
- Locations
- 🇺🇸
Cancer Center of Kansas-Independence, Independence, Kansas, United States
🇺🇸Bismarck Cancer Center, Bismarck, North Dakota, United States
🇺🇸Kalispell Regional Medical Center, Kalispell, Montana, United States